|
Despite their best efforts, today Psoriasis affects not 100 Oregonians, but 7,500,000 Americans. About $11 billion dollars are spent annually on direct and indirect costs of the disease.
Recently, a headline read: 3 Drug makers Developing Revolutionary Psoriasis Treatments. Should we all be excited with this headline?
MY TAKE: I have absolutely no idea what drugs exist today for Psoriasis, nor can I even pronounce these newly developed drugs, but as the article pointed out, “some predict that the worldwide market for Psoriasis drugs could double by 2022 to more than $7.6 billion.” Which is great news for drug company investors, but what about patients?
David Weakley, MD was an open minded Dallas dermatologist who told me that doctors in his field really couldn’t help Psoriasis patients other than temporarily with cortisone and UV light boxes. “I wish we knew the cause of it,” he told me one day. I asked him if he would help me confirm my suspicions on the fungus link to Psoriasis. If he would prescribe two drugs, Diflucan and Nystatin for 20 of his many Psoriasis patients, I would place them on my Kaufmann 1 diet during the month they were on these drugs.
The results proved to him and confirmed to me that some Psoriasis patients suffer from systemic yeast problems. The small study was never concluded as Dr. Weakley passed before it ever got published. But he did let me offer the antifungal approach to many others with Psoriasis (and other conditions) after witnessing the successes that he did.
To me, the diet and antifungal drugs were the “revolutionary Psoriasis treatments” because they offered hope. These 3 new drugs will likely hush symptoms for 4-6 hours at a time, thereby becoming the same “expensive urine” temporary treatments that so many allopathic doctors have long accused safe supplements of being.
{flike}
|
